{"SPADE_N_14430": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_N_14430", "Peptide Name": "CZS-4 (cruzioseptin-4; natural AMPs; frog, amphibians, animals, UCLL1c; XXA)", "Source": "the splendid leaf frog,Cruziohyla calcarifer, Central and South America", "Family": "Not found", "Gene": "Not found", "Sequence": "GFLDVIKHVGKAALSVVSHLINE", "Sequence Length": 23, "UniProt Entry": "Ref", "Protein Existence": "Not found", "Biological Activity": ["Anti-Gram+", "Anti-Gram-", "Antifungal", "Antifungal", "Antiparasitic", "Antimalarial"], "Target Organism": "Not found", "Hemolytic Activity": "Not found", "Cytotoxicity": "Not found", "Binding Target": "Not found", "Linear/Cyclic": "Not found", "N-terminal Modification": "Not found", "C-terminal Modification": "Not found", "Stereochemistry": "Not found", "Structure Description": "Not found", "Formula": "Not found", "Mass": 2446.84, "PI": 6.93, "Hydrophobicity": 0.72, "Half Life": "Not found", "Function": "Not found", "Literature": [{"Author": "Proaño-Bolaños C, Morán-Marcillo G, Espinosa de Los Monteros-Silva N, Bermúdez-Puga S, Salazar MA, Blasco-Zúñiga A, Cuesta S, Molina C, Espinosa F, Meneses L, Rojas-Silva P, Zapata Mena S, Sáenz FE, Rivera I M, Costales JA.2024", "Reference": "Microbiol Spectr. 2024 Jul 16:e0333923. doi: 10.1128/spectrum.03339-23.PubMed", "Title": "Bioactivity of synthetic peptides from Ecuadorian frog skin secretions against Leishmania mexicana, Plasmodium falciparum, and Trypanosoma cruzi."}], "Frequent Amino Acids": "VLA", "Absent Amino Acids": "CMOPQRTUWY", "Basic Residues": 4, "Acidic Residues": 2, "Hydrophobic Residues": 12, "Polar Residues": 13, "Positive Residues": 4, "Negative Residues": 2, "Net Charge": 2, "Comments": "Sequence analysis: APD analysis reveals that this sequence is similar (86.96%) toCZS-2V: 17%, L:13%. GRAVY: 0.717; mol Wt: 2446.873; mol formula: C112H185N29O31; mol ex coeff: 0.Activity: Active against E. coli (MIC 13.09 uM), S. aureus (MIC 26.18 uM), and C. albicans (MIC 52.36 uM).Parasites: T. cruzi Trypomastigotes (IC50 1.55 uM) or Amastigotes (IC50 30.65 uM), P. falciparum NF54 (IC50 13.86 uM) or TM90C2B (IC50 4.87 uM), L. Mexicana (IC50 0.09 uM).In vitro toxicity: 4% RBC: hemolysis of 13% at 128 uM (HC50>100 uM), low hemo.lytic.", "Similar Sequences": [{"SPADE_ID": "SPADE_N_05686", "Similarity": 0.8695652173913043, "Sequence": "GFLDVIKHVGKAALGVVTHLINQ"}, {"SPADE_ID": "SPADE_N_14014", "Similarity": 0.8, "Sequence": "GLINEKKVQQYLDEKLPNGVVKGALKSLVHKAAKNQNLCAFNVDTVGMCDADCKRQGKAKGVCHGTKCKCDVELSYKK"}, {"SPADE_ID": "SPADE_N_05685", "Similarity": 0.7391304347826086, "Sequence": "GFLDVVKHIGKAALGAVTHLINQ"}]}}}